Cite
HARVARD Citation
Barr, H. et al. (2018). Ninety-minute daratumumab infusion is safe in multiple myeloma. Leukemia. 32 (11), pp. 2495-2518. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Barr, H. et al. (2018). Ninety-minute daratumumab infusion is safe in multiple myeloma. Leukemia. 32 (11), pp. 2495-2518. [Online].